|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (2008)) |
IUPAC Name ![]() |
| 2-[[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl]-3-phenylpropanoyl]amino]acetic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8245 | alvimopan |
Synonyms ![]() |
| ADL 8-2698 |
| Entereg® |
Database Links ![]() |
|
| CAS Registry No. | 156053-89-3 |
| ChEMBL Ligand | CHEMBL270190 |
| DrugBank Ligand | DB06274 |
| PubChem CID | 5488548 |
| Search Google for chemical match using the InChIKey | UPNUIXSCZBYVBB-JVFUWBCBSA-N |
| Search Google for chemicals with the same backbone | UPNUIXSCZBYVBB |
| Search PubMed clinical trials | alvimopan |
| Search PubMed titles | alvimopan |
| Search PubMed titles/abstracts | alvimopan |
| Wikipedia | Alvimopan |
| Comments |
| Alvimopan is a peripherally acting mu-opioid receptor antagonist , or PAMORA. |